Literature DB >> 21205863

Disruption of telomerase trafficking by TCAB1 mutation causes dyskeratosis congenita.

Franklin Zhong1, Sharon A Savage, Marina Shkreli, Neelam Giri, Lea Jessop, Timothy Myers, Renee Chen, Blanche P Alter, Steven E Artandi.   

Abstract

Dyskeratosis congenita (DC) is a genetic disorder of defective tissue maintenance and cancer predisposition caused by short telomeres and impaired stem cell function. Telomerase mutations are thought to precipitate DC by reducing either the catalytic activity or the overall levels of the telomerase complex. However, the underlying genetic mutations and the mechanisms of telomere shortening remain unknown for as many as 50% of DC patients, who lack mutations in genes controlling telomere homeostasis. Here, we show that disruption of telomerase trafficking accounts for unknown cases of DC. We identify DC patients with missense mutations in TCAB1, a telomerase holoenzyme protein that facilitates trafficking of telomerase to Cajal bodies. Compound heterozygous mutations in TCAB1 disrupt telomerase localization to Cajal bodies, resulting in misdirection of telomerase RNA to nucleoli, which prevents telomerase from elongating telomeres. Our findings establish telomerase mislocalization as a novel cause of DC, and suggest that telomerase trafficking defects may contribute more broadly to the pathogenesis of telomere-related disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21205863      PMCID: PMC3012932          DOI: 10.1101/gad.2006411

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  30 in total

1.  A telomerase component is defective in the human disease dyskeratosis congenita.

Authors:  J R Mitchell; E Wood; K Collins
Journal:  Nature       Date:  1999-12-02       Impact factor: 49.962

2.  Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC.

Authors:  Tom Vulliamy; Anna Marrone; Richard Szydlo; Amanda Walne; Philip J Mason; Inderjeet Dokal
Journal:  Nat Genet       Date:  2004-04-18       Impact factor: 38.330

3.  MutationTaster evaluates disease-causing potential of sequence alterations.

Authors:  Jana Marie Schwarz; Christian Rödelsperger; Markus Schuelke; Dominik Seelow
Journal:  Nat Methods       Date:  2010-08       Impact factor: 28.547

Review 4.  WD40 proteins propel cellular networks.

Authors:  Christian U Stirnimann; Evangelia Petsalaki; Robert B Russell; Christoph W Müller
Journal:  Trends Biochem Sci       Date:  2010-05-05       Impact factor: 13.807

Review 5.  Linking functional decline of telomeres, mitochondria and stem cells during ageing.

Authors:  Ergün Sahin; Ronald A Depinho
Journal:  Nature       Date:  2010-03-25       Impact factor: 49.962

Review 6.  Telomere diseases.

Authors:  Rodrigo T Calado; Neal S Young
Journal:  N Engl J Med       Date:  2009-12-10       Impact factor: 91.245

Review 7.  Regulation of telomerase by telomeric proteins.

Authors:  Agata Smogorzewska; Titia de Lange
Journal:  Annu Rev Biochem       Date:  2004       Impact factor: 23.643

8.  Dyskeratosis congenita.

Authors:  Monica Bessler; David B Wilson; Philip J Mason
Journal:  FEBS Lett       Date:  2010-05-21       Impact factor: 4.124

9.  Telomerase RNA accumulates in Cajal bodies in human cancer cells.

Authors:  Yusheng Zhu; Rebecca L Tomlinson; Andrew A Lukowiak; Rebecca M Terns; Michael P Terns
Journal:  Mol Biol Cell       Date:  2003-10-03       Impact factor: 4.138

10.  Human telomerase RNA and box H/ACA scaRNAs share a common Cajal body-specific localization signal.

Authors:  Beáta E Jády; Edouard Bertrand; Tamás Kiss
Journal:  J Cell Biol       Date:  2004-02-23       Impact factor: 10.539

View more
  123 in total

Review 1.  Small RNAs with big implications: new insights into H/ACA snoRNA function and their role in human disease.

Authors:  Mary McMahon; Adrian Contreras; Davide Ruggero
Journal:  Wiley Interdiscip Rev RNA       Date:  2014-10-31       Impact factor: 9.957

2.  Structure of the Shq1-Cbf5-Nop10-Gar1 complex and implications for H/ACA RNP biogenesis and dyskeratosis congenita.

Authors:  Shuang Li; Jingqi Duan; Dandan Li; Shoucai Ma; Keqiong Ye
Journal:  EMBO J       Date:  2011-11-25       Impact factor: 11.598

3.  Telomerase and retrotransposons: reverse transcriptases that shaped genomes.

Authors:  Marlene Belfort; M Joan Curcio; Neal F Lue
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-20       Impact factor: 11.205

4.  Telomerase recruitment requires both TCAB1 and Cajal bodies independently.

Authors:  J Lewis Stern; Katherine G Zyner; Hilda A Pickett; Scott B Cohen; Tracy M Bryan
Journal:  Mol Cell Biol       Date:  2012-04-30       Impact factor: 4.272

Review 5.  Genetic interstitial lung disease.

Authors:  Megan Stuebner Devine; Christine Kim Garcia
Journal:  Clin Chest Med       Date:  2011-12-06       Impact factor: 2.878

Review 6.  The molecular genetics of the telomere biology disorders.

Authors:  Alison A Bertuch
Journal:  RNA Biol       Date:  2015-09-23       Impact factor: 4.652

Review 7.  Understanding telomere diseases through analysis of patient-derived iPS cells.

Authors:  Luis F Z Batista; Steven E Artandi
Journal:  Curr Opin Genet Dev       Date:  2013-08-28       Impact factor: 5.578

8.  Small-Molecule PAPD5 Inhibitors Restore Telomerase Activity in Patient Stem Cells.

Authors:  Neha Nagpal; Jianing Wang; Jing Zeng; Emily Lo; Diane H Moon; Kevin Luk; Roman O Braun; Lauri M Burroughs; Sioban B Keel; Christopher Reilly; R Coleman Lindsley; Scot A Wolfe; Albert K Tai; Patrick Cahan; Daniel E Bauer; Yick W Fong; Suneet Agarwal
Journal:  Cell Stem Cell       Date:  2020-04-21       Impact factor: 24.633

Review 9.  The genetics of dyskeratosis congenita.

Authors:  Philip J Mason; Monica Bessler
Journal:  Cancer Genet       Date:  2011-12

Review 10.  The Cajal body and the nucleolus: "In a relationship" or "It's complicated"?

Authors:  Laura Trinkle-Mulcahy; Judith E Sleeman
Journal:  RNA Biol       Date:  2016-09-23       Impact factor: 4.652

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.